161 related articles for article (PubMed ID: 26693680)
1. A CatalyCEST MRI Contrast Agent that Can Simultaneously Detect Two Enzyme Activities.
Fernández-Cuervo G; Sinharay S; Pagel MD
Chembiochem; 2016 Mar; 17(5):383-7. PubMed ID: 26693680
[TBL] [Abstract][Full Text] [Related]
2. A single diamagnetic catalyCEST MRI contrast agent that detects cathepsin B enzyme activity by using a ratio of two CEST signals.
Hingorani DV; Montano LA; Randtke EA; Lee YS; Cárdenas-Rodríguez J; Pagel MD
Contrast Media Mol Imaging; 2016; 11(2):130-8. PubMed ID: 26633584
[TBL] [Abstract][Full Text] [Related]
3. Detection of Sulfatase Enzyme Activity with a CatalyCEST MRI Contrast Agent.
Sinharay S; Fernández-Cuervo G; Acfalle JP; Pagel MD
Chemistry; 2016 May; 22(19):6491-5. PubMed ID: 26956002
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive detection of enzyme activity in tumor models of human ovarian cancer using catalyCEST MRI.
Sinharay S; Randtke EA; Jones KM; Howison CM; Chambers SK; Kobayashi H; Pagel MD
Magn Reson Med; 2017 May; 77(5):2005-2014. PubMed ID: 27221386
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous Evaluations of pH and Enzyme Activity with a CEST MRI Contrast Agent.
Kombala CJ; Lokugama SD; Kotrotsou A; Li T; Pollard AC; Pagel MD
ACS Sens; 2021 Dec; 6(12):4535-4544. PubMed ID: 34856102
[TBL] [Abstract][Full Text] [Related]
6. A catalyCEST MRI contrast agent that detects the enzyme-catalyzed creation of a covalent bond.
Hingorani DV; Randtke EA; Pagel MD
J Am Chem Soc; 2013 May; 135(17):6396-8. PubMed ID: 23601132
[TBL] [Abstract][Full Text] [Related]
7. Detecting in vivo urokinase plasminogen activator activity with a catalyCEST MRI contrast agent.
Sinharay S; Howison CM; Baker AF; Pagel MD
NMR Biomed; 2017 Jul; 30(7):. PubMed ID: 28370884
[TBL] [Abstract][Full Text] [Related]
8. A self-calibrating PARACEST MRI contrast agent that detects esterase enzyme activity.
Li Y; Sheth VR; Liu G; Pagel MD
Contrast Media Mol Imaging; 2011; 6(4):219-28. PubMed ID: 21861282
[TBL] [Abstract][Full Text] [Related]
9. N-Aryl Amides as Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Contrast Agents.
Cai X; Zhang J; Lu J; Yi L; Han Z; Zhang S; Yang X; Liu G
Chemistry; 2020 Sep; 26(51):11705-11709. PubMed ID: 32639618
[TBL] [Abstract][Full Text] [Related]
10. Detection of in vivo enzyme activity with CatalyCEST MRI.
Yoo B; Sheth VR; Howison CM; Douglas MJ; Pineda CT; Maine EA; Baker AF; Pagel MD
Magn Reson Med; 2014 Mar; 71(3):1221-30. PubMed ID: 23640714
[TBL] [Abstract][Full Text] [Related]
11. Using two chemical exchange saturation transfer magnetic resonance imaging contrast agents for molecular imaging studies.
Ali MM; Liu G; Shah T; Flask CA; Pagel MD
Acc Chem Res; 2009 Jul; 42(7):915-24. PubMed ID: 19514717
[TBL] [Abstract][Full Text] [Related]
12. Detection of Enzyme Activity and Inhibition during Studies in Solution, In Vitro and In Vivo with CatalyCEST MRI.
Sinharay S; Randtke EA; Howison CM; Ignatenko NA; Pagel MD
Mol Imaging Biol; 2018 Apr; 20(2):240-248. PubMed ID: 28726131
[TBL] [Abstract][Full Text] [Related]
13. Monitoring enzyme activity using a diamagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent.
Liu G; Liang Y; Bar-Shir A; Chan KW; Galpoththawela CS; Bernard SM; Tse T; Yadav NN; Walczak P; McMahon MT; Bulte JW; van Zijl PC; Gilad AA
J Am Chem Soc; 2011 Oct; 133(41):16326-9. PubMed ID: 21919523
[TBL] [Abstract][Full Text] [Related]
14. Diamagnetic Imaging Agents with a Modular Chemical Design for Quantitative Detection of β-Galactosidase and β-Glucuronidase Activities with CatalyCEST MRI.
Fernández-Cuervo G; Tucker KA; Malm SW; Jones KM; Pagel MD
Bioconjug Chem; 2016 Oct; 27(10):2549-2557. PubMed ID: 27657647
[TBL] [Abstract][Full Text] [Related]
15. Imaging chemical exchange saturation transfer (CEST) effects following tumor-selective acidification using lonidamine.
McVicar N; Li AX; Meakin SO; Bartha R
NMR Biomed; 2015 May; 28(5):566-75. PubMed ID: 25808190
[TBL] [Abstract][Full Text] [Related]
16. Chemical Exchange Saturation Transfer (CEST) Agents: Quantum Chemistry and MRI.
Li J; Feng X; Zhu W; Oskolkov N; Zhou T; Kim BK; Baig N; McMahon MT; Oldfield E
Chemistry; 2016 Jan; 22(1):264-71. PubMed ID: 26616530
[TBL] [Abstract][Full Text] [Related]
17. Assessments of tumor metabolism with CEST MRI.
Goldenberg JM; Pagel MD
NMR Biomed; 2019 Oct; 32(10):e3943. PubMed ID: 29938857
[TBL] [Abstract][Full Text] [Related]
18. Unlabeled aspirin as an activatable theranostic MRI agent for breast cancer.
Pavuluri K; Yang E; Ayyappan V; Sonkar K; Tan Z; Tressler CM; Bo S; Bibic A; Glunde K; McMahon MT
Theranostics; 2022; 12(4):1937-1951. PubMed ID: 35198081
[No Abstract] [Full Text] [Related]
19. Screening CEST contrast agents using ultrafast CEST imaging.
Xu X; Yadav NN; Song X; McMahon MT; Jerschow A; van Zijl PC; Xu J
J Magn Reson; 2016 Apr; 265():224-9. PubMed ID: 26969814
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
